These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1324635)

  • 1. Once-a-week azithromycin in AIDS patients: tolerability, kinetics, and effects on zidovudine disposition.
    Chave JP; Munafo A; Chatton JY; Dayer P; Glauser MP; Biollaz J
    Antimicrob Agents Chemother; 1992 May; 36(5):1013-8. PubMed ID: 1324635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interaction of megestrol acetate with zidovudine in human immunodeficiency virus-infected patients.
    Van Harken DR; Pei JC; Wagner J; Pike IM
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2480-3. PubMed ID: 9371353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex.
    Hewitt RG; Morse GD; Lawrence WD; Maliszewski ML; Santora J; Bartos L; Bonnem E; Poiesz B
    Antimicrob Agents Chemother; 1993 Mar; 37(3):512-22. PubMed ID: 8460920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin pharmacokinetics in the serum and its distribution to the skin in healthy dogs and dogs with pyoderma.
    Zur G; Soback S; Weiss Y; Perry E; Lavy E; Britzi M
    Vet J; 2014 Apr; 200(1):122-6. PubMed ID: 24472431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of azithromycin in human tonsillar tissue.
    Foulds G; Chan KH; Johnson JT; Shepard RM; Johnson RB
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):853-6. PubMed ID: 1662631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of clarithromycin and zidovudine in patients with AIDS.
    Vance E; Watson-Bitar M; Gustavson L; Kazanjian P
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1355-60. PubMed ID: 7574530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.
    Chien SC; Chow AT; Rogge MC; Williams RR; Hendrix CW
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1765-9. PubMed ID: 9257757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence assessment of zidovudine (Retrovir) syrup, solution, and capsule formulations in patients infected with human immunodeficiency virus.
    Drew RH; Weller S; Gallis HA; Walmer KA; Bartlett JA; Blum MR
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1801-3. PubMed ID: 2589846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of azithromycin on human serum sensitivity of Pseudomonas aeruginosa].
    Tateda K; Yamaguchi K; Furuya N; Hirakata Y; Ohno A; Goto S
    Kansenshogaku Zasshi; 1992 Sep; 66(9):1236-42. PubMed ID: 1331267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study on azithromycin in 10% fine granules and 100mg capsules in the field of pediatrics].
    Motohiro T; Nagai K; Yamada S; Tsumura N; Yamada T; Oda K; Sakata Y; Kato H; Gakuen Y; Imai S; Sasaki H; Morita J; Ikezawa S; Matsuo Y; Yamashita Y; Aramaki M; Araki H; Yasuoka C; Hayashi M; Ono E; Hashimoto N; Kubota K; Kawakami A; Toyoda A; Wada M
    Jpn J Antibiot; 1997 Mar; 50(3):272-97. PubMed ID: 9634360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus.
    Boucher FD; Modlin JF; Weller S; Ruff A; Mirochnick M; Pelton S; Wilfert C; McKinney R; Crain MJ; Elkins MM
    J Pediatr; 1993 Jan; 122(1):137-44. PubMed ID: 8419601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin.
    Chandra R; Liu P; Breen JD; Fisher J; Xie C; LaBadie R; Benner RJ; Benincosa LJ; Sharma A
    Clin Pharmacokinet; 2007; 46(3):247-59. PubMed ID: 17328583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis.
    Wilms EB; Touw DJ; Heijerman HG
    Ther Drug Monit; 2006 Apr; 28(2):219-25. PubMed ID: 16628134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacteriological, pharmacokinetic and clinical evaluation of azithromycin in the pediatric field].
    Akita H; Sato Y; Kusumoto Y; Iwata S; Takeuchi Y; Aoyama T; Yokota T; Sunakawa K
    Jpn J Antibiot; 1996 Oct; 49(10):899-916. PubMed ID: 8986553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection.
    Balis FM; Pizzo PA; Eddy J; Wilfert C; McKinney R; Scott G; Murphy RF; Jarosinski PF; Falloon J; Poplack DG
    J Pediatr; 1989 May; 114(5):880-4. PubMed ID: 2715903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of single and chronic dose zidovudine in two HIV positive patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Gallicano KD; Tobe S; Sahai J; McGilveray IJ; Cameron DW; Kriger F; Garber G
    J Acquir Immune Defic Syndr (1988); 1992; 5(3):242-50. PubMed ID: 1740749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal.
    Unadkat JD; Collier AC; Crosby SS; Cummings D; Opheim KE; Corey L
    AIDS; 1990 Mar; 4(3):229-32. PubMed ID: 2350441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of zidovudine: inter and intraindividual variability and relationship to long term efficacy and toxicity.
    Mentré F; Escolano S; Diquet B; Golmard JL; Mallet A
    Eur J Clin Pharmacol; 1993; 45(5):397-407. PubMed ID: 8112367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two dosages of azithromycin for three days versus penicillin V for ten days in acute group A streptococcal tonsillopharyngitis.
    Cohen R; Reinert P; De La Rocque F; Levy C; Boucherat M; Robert M; Navel M; Brahimi N; Deforche D; Palestro B; Bingen E
    Pediatr Infect Dis J; 2002 Apr; 21(4):297-303. PubMed ID: 12075760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azithromycin concentrations in sinus fluid and mucosa after oral administration.
    Karma P; Pukander J; Penttilä M
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):856-9. PubMed ID: 1662632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.